• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
78,151.45 964.58
( 1.25%)
Global Indices
Nasdaq
52,169.86 -404.11
(-0.77%)
Dow Jones
7,480.34 -74.43
(-0.99%)
Hang Seng
63,887.74 -2,947.80
(-4.41%)
Nikkei 225
10,574.52 2.28
(0.02%)
Forex
USD-INR
96.36 0.10
(0.10%)
EUR-INR
110.37 0.25
(0.23%)
GBP-INR
130.11 0.62
(0.47%)
JPY-INR
0.59 0.00
(0.06%)

EQUITY - MARKET SCREENER

Bal Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524824
INE083D01012
65.3864135
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
BALPHARMA
20.53
138.59
EPS(TTM)
Face Value()
Div & Yield %
4.24
10
1.38
 

hcl technologies ltd
Radhe Developers (India) standalone net profit declines 95.13% in the March 2026 quarter
May 25,2026
Net profit of Radhe Developers (India) declined 95.13% to Rs 0.11 crore in the quarter ended March 2026 as against Rs 2.26 crore during the previous quarter ended March 2025. Sales declined 42.96% to Rs 2.39 crore in the quarter ended March 2026 as against Rs 4.19 crore during the previous quarter ended March 2025.

For the full year,net profit rose 140.00% to Rs 3.24 crore in the year ended March 2026 as against Rs 1.35 crore during the previous year ended March 2025. Sales rose 45.04% to Rs 11.11 crore in the year ended March 2026 as against Rs 7.66 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2.394.19 -43 11.117.66 45
OPM %9.2168.97 -44.7341.51 -
PBDT0.112.44 -95 4.312.20 96
PBT-0.162.25 PL 3.431.46 135
NP0.112.26 -95 3.241.35 140